Product Information

CICLOPIROX 0.77% TOPICAL SUSP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7331 per ML under NDC 45802040046. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 15, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Ciclopirox Olamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CICLOPIROX 0.77% TOPICAL SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 75.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.